The functioning in chronic illness –— a key determinant of treatment efficacy in patients with metabolic syndrome

Abstract

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

Adherence to lipid-lowering therapy

“…The project applied in the ELECTRA-SIRIO 2 trial [21,22] is aimed to support adherence to the study medication. It consists of diagnosis regarding readiness for discharge from hospital [9,23], adherence to medication [24][25][26] and functioning in chronic illness [27][28][29][30][31], individualized education [32][33][34] and motivation [18]. The results of the MEDMOTION project, planned after the completion of the one-year follow-up of 500 patients in the ELECTRA-SIRIO 2 study, are expected soon.…”